Skip to main content

Mesoblast Ltd

MESO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001345099

No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.

Other share classesMEOBF

Q4 2025 vs. Q3 2025

How the institutions holding Mesoblast Ltd changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of MESO: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders6875+7
Shares3.66M4.20M+540.8K (+14.8%)
Value$58.9M$75.7M+$16.8M (+28.5%)

New holders (14)

Institutions that held Mesoblast Ltd at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to MESO in Q4 2025
InstitutionSharesValue% of portfolio
Citadel Advisors LLC131,388$2.37M0.00%
Rialto Wealth Management, LLC46,500$838.9K0.20%
Point72 Asset Management, L.P.38,185$688.9K0.00%
Quadrature Capital Ltd26,566$479.3K0.00%
Polen Capital Management LLC23,005$415.0K0.00%
Wiley Bros.-Aintree Capital, LLC18,512$334.0K0.00%
Opal Capital LLC18,279$306.7K0.08%
BCS Private Wealth Management, Inc.16,000$288.6K0.10%
Marshall Wace, LLP15,828$285.5K0.00%
NBC Securities, Inc.4,954$89.4K0.01%
Caitong International Asset Management Co., Ltd1,766$31.9K0.01%
Basecamp Wealth Advisors LLC177$3.19K0.00%
SageView Advisory Group, LLC11$1990.00%
The PNC Financial Services Group, Inc.3$540.00%

Sold out (7)

Institutions that held Mesoblast Ltd at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of MESO in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Rockbridge Investment Management, LCC49,150$791.8K
Sanctuary Advisors, LLC14,364$231.4K
Concurrent Investment Advisors, LLC10,000$161.1K
Simplex Trading, LLC1,713$27.0K
Advisory Services Network, LLC475$7.65K
Medallion Wealth Advisors, LLC200$3.22K
Principal Securities, Inc.7$113